Raju Kandimalla, Roy Masius, Willemien Beukers, Chris H. Bangma, Torben F. Orntoft, Lars Dyrskjot, Nikki van Leeuwen, Hester Lingsma, Angela A. G. van Tilborg, Ellen C. Zwarthoff Department of Pathology, Erasmus MC, Rotterdam, The Netherlands Department of Urology, Erasmus MC, Rotterdam, The Netherlands Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark Department of ...

P. A. Wielopolski, P. Ciet, G. P. Krestin, M. H. Lequin, H. Tiddens, and R. Manniesing Radiology, Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands, Department of Medical-Diagnostic Sciences and Therapies, Policlinico Universitario di Padova, Padova, Italy, Department of Pulmonology, Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands, Department of Informatics and Radiology...

Rotterdam Study, Piter J. Bosma, Irene M. van der Meer, Conny T. Bakker, Albert Hofman, Marianne Paul-Abrahamse, and Jacqueline C. Witteman ( Liver Center, Academic Medical Center, Meibergdreef 9, 1105AZ Amsterdam, The Netherlands; 2 Department of Epidemiology & Biostatistics, Erasmus MC, University Medical Center, Rotterdam, PO Box 1738, 3000DR Rotterdam, The Netherlands; * author for correspo...

University of Illinois at Urbana-Champaign, Department of Agricultural & Consumer Economics, Marketing/Decision Sciences Group, 1301 West Gregory Drive, Urbana, Ill inois 61801 Wageningen University, Department of Social sciences, Marketing & Consumer Behavior Group, Hollandseweg 1, 6706 KN Wageningen, The Netherlands Rotterdam School of Management, Erasmus University Rotterdam, P.O. Box 1738, ...

Dissemination of prostate-specific antigen (PSA) testing in the United States coincided with an increasing incidence of prostate cancer, a shift to earlier stage disease at diagnosis, and decreasing prostate cancer mortality. We compared PSA screening performance with respect to prostate cancer detection in the US population vs in the Rotterdam section of the European Randomized Study of Screen...

Dept of Medical Oncology, Erasmus University Medical Center – Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands; Dept of Pharmaceutical Sciences, St Jude Children’s Research Hospital, Memphis, TN; Dept of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Dept of Trials and Statistics,...

Van Baalen, C.A., C. Els, L. Sprong, R. van Beek, E. van der Vries, A.D.M.E. Osterhaus 6 and G.F. Rimmelzwaan 7 1 Viroclinics Biosciences, Rotterdam, The Netherlands; 2 Erasmus MC Department of 8 Viroscience, Rotterdam, The Netherlands. 9 10 # Address correspondence to: [email protected] 11 12 Institutional addresses: 13 Viroclinics Biosciences; Marconistraat 16; 3029 AK Rotterdam; The Net...

Van Baalen, C.A., C. Els, L. Sprong, R. van Beek, E. van der Vries, A.D.M.E. Osterhaus 6 and G.F. Rimmelzwaan 7 1 Viroclinics Biosciences, Rotterdam, The Netherlands; 2 Erasmus MC Department of 8 Viroscience, Rotterdam, The Netherlands. 9 10 # Address correspondence to: [email protected] 11 12 Institutional addresses: 13 Viroclinics Biosciences; Marconistraat 16; 3029 AK Rotterdam; The Net...

OBJECTIVE To determine the risk of metabolic complications, primarily metabolic syndrome, in all polycystic ovary syndrome (PCOS) phenotypes compared with control subjects. DESIGN Retrospective chart review. SETTING University practice. PATIENT(S) Women with PCOS (Rotterdam definition; n = 258) and women without PCOS seen during the same time period for an annual exam used as controls (n ...